Patents by Inventor Dave Michael Anstrom

Dave Michael Anstrom has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11896659
    Abstract: The present invention relates to the use of an immunogenic composition that comprises a porcine circovirus type 3 (PCV3) antigen for treatment of several clinical manifestations (diseases). Preferably, the clinical manifestations are associated with a PCV3 infection.
    Type: Grant
    Filed: November 23, 2022
    Date of Patent: February 13, 2024
    Inventors: Arun Iyer, Luis Alejandro Hernandez, Abby Patterson, Bailey Arruda, Luis Gabriel Gimenez-Lirola, Dave Michael Anstrom, Eric M. Vaughn, Pablo E Pineyro Pineiro, Troy James Kaiser, Joseph Ralph Hermann
  • Publication number: 20230302113
    Abstract: The present invention relates to the use of an immunogenic composition that comprises a porcine circovirus type 3 (PCV3) antigen for treatment of several clinical manifestations (diseases). Preferably, the clinical manifestations are associated with a PCV3 infection.
    Type: Application
    Filed: November 23, 2022
    Publication date: September 28, 2023
    Inventors: Arun IYER, Luis Alejandro Hernandez, Abby Patterson, Bailey Arruda, Luis Gabriel Gimenez-Lirola, Dave Michael Anstrom, Eric M. Vaughn, Pablo E Pineyro Pineiro, Troy James Kaiser, Joseph Ralph Hermann
  • Patent number: 11701419
    Abstract: The present invention relates to the use of an immunogenic composition that comprises a porcine circovirus type 3 (PCV3) antigen for treatment of several clinical manifestations (diseases). Preferably, the clinical manifestations are associated with a PCV3 infection.
    Type: Grant
    Filed: April 6, 2020
    Date of Patent: July 18, 2023
    Inventors: Arun Iyer, Luis Alejandro Hernandez, Abby Patterson, Bailey Arruda, Luis Gabriel Gimenez-Lirola, Dave Michael Anstrom, Eric M. Vaughn, Pablo E. Pineyro Pineiro, Troy James Kaiser, Joseph Ralph Hermann
  • Publication number: 20210128712
    Abstract: The present invention relates to the use of an immunogenic composition that comprises a porcine circovirus type 3 (PCV3) antigen for treatment of several clinical manifestations (diseases). Preferably, the clinical manifestations are associated with a PCV3 infection.
    Type: Application
    Filed: April 6, 2020
    Publication date: May 6, 2021
    Inventors: Arun IYER, Luis Alejandro Hernandez, Abby Patterson, Bailey Arruda, Luis Gabriel Gimenez-Lirola, Dave Michael Anstrom, Eric M. Vaughn